Industries > Pharma > Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031

Forecasts by Molecule Type (Small Molecule, Large Molecule), by Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others), by Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), by Container Type (Bottles, Ampoules, Vials, Pre-filled Syringes, Bags), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Others), by Service (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 16 November 2021
PAGES: 526
PRODUCT CODE: PHA1156
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

As CMOs become Integrated into Pharmaceutical Businesses’ Value Chains, This Business Model is Projected to be a Resounding Success
As an alternative to pharmaceutical corporations’ in-house research and production divisions, contract manufacturing organisations (CMOs) have emerged in the last several decades. As contract manufacturing organisations (CMOs) become more and more integrated into pharmaceutical businesses’ value chains, this business model is proving to be a resounding success. The industry as a whole is growing, but many CMOs are having to deal with difficulties they have never faced before. Because of intense competition, rising costs, ongoing technical advancements, and an increase in merger and acquisition activity, businesses are forced to consider what actions they might take to protect or enhance their position in this competitive market.

CMO of Sterile Injectable Drugs Market Growth Drivers
• Outsourced biologic drug product production capabilities
• High growth in developing markets
• Lucrative demand for biologics
• More sterile injectable drugs are losing their patents, including biologics, and the generic parenteral and biosimilar markets are growing
• Increased demand for patient-friendly parenteral administration methods and prefilled syringes
• The ageing population and the ailments that come with it (cancer, diabetes, autoimmune, metabolic, nervous system disorders, etc.)
• High-potency (HPAPI and cytotoxic) medicinal product production
• Adding second-source drug product manufacturers to the supply chain reduces supply chain risk

What Factors Are Challenging Market Growth
• Capabilities in analytical development and/or testing
• Identifying CMOs with ADC filling capability
• Available sterile filling capacity for modest amounts
• Visual inspection
• Assay transfer

What are the Market Opportunities?
• Emerging business segments and economies
• India is a favorable sourcing destination for injectables
• Increasing outsourcing activities by major pharmaceutical companies towards emerging markets for cost savings

Discover how to stay ahead
Our 520+ page report provides 680+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. See how to exploit the opportunities.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets

Molecule Type
• Small Molecule
• Large Molecule

Type
• Monoclonal Antibodies (mAbs)
• Cytokines
• Insulin
• Peptide Hormones
• Vaccines
• Immunoglobulins
• Blood Factors
• Peptide Antibiotics
• Others

Application
• Cancer
• Diabetes
• Cardiovascular Diseases
• CNS
• Infectious
• Others

Container Type
• Bottles
• Ampoules
• Vials
• Prefilled Syringes
• Bags

Route of Administration
• Subcutaneous (SC)
• Intravenous (IV)
• Intramuscular (IM)
• Others

Service
• Bioanalytical Testing
• Method Development & Validation
• Stability Testing
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

By Region

• North America
• U.S.
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Australia
• South-East Asia
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for contract manufacturing outsourcing (CMO) of sterile injectable drugs Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the major companies involved in the contract manufacturing outsourcing (CMO) of sterile injectable drugs market. Some of the companies profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.

How the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market report helps you
In summary, our 500+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market, with forecasts for 2 molecule types, 8 types, 6 applications, 5 container types, 4 route of administration, and 4 services, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2031 for 5 regional and 17 key national markets– See forecasts for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, and South-East Asia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the companies involved in the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market. Some of the company’s profiled in this report include Aenova Group, Almac Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Evonik Industries AG, Famar Health Care Services, Fresenius Kabi Ag, Grifols SA, Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Patheon, Inc. (Thermo Fischer), Pfizer CentreOne, Recipharm AB, and Siegfried Holding AG among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market and leading companies. You will find data, trends, and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031: Forecasts by Molecule Type (Small Molecule, Large Molecule), by Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others), by Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), by Container Type (Bottles, Ampoules, Vials, Pre-filled Syringes, Bags), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Others), by Service (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2022-2032

The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.

01 December 2022

READ

Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2023-2033

The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.

01 December 2022

READ

Visiongain Publishes Medical Imaging Market Report 2022-2032

The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.

30 November 2022

READ

Visiongain Publishes Antibody Drug Conjugates Market Report 2022-2032

The global antibody drug conjugates market was valued at US$3,668 million in 2021 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

28 November 2022

READ